These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25941193)

  • 21. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis.
    Hünemörder S; Treder J; Ahrens S; Schumacher V; Paust HJ; Menter T; Matthys P; Kamradt T; Meyer-Schwesinger C; Panzer U; Hopfer H; Mittrücker HW
    J Pathol; 2015 Sep; 237(1):62-71. PubMed ID: 25965582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
    Venkatesha SH; Dudics S; Acharya B; Moudgil KD
    Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of IL-18BP on mRNA expression of inflammatory cytokines and apoptotic genes in renal injury induced by infrarenal aortic occlusion.
    Gönül Y; Genç A; Ahsen A; Bal A; Hazman Ö; Toktaş M; Ulu MS; Özdinç Ş; Songur A
    J Surg Res; 2016 May; 202(1):33-42. PubMed ID: 27083945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new era for innate immunity.
    Montero Vega MT
    Allergol Immunopathol (Madr); 2008; 36(3):164-75. PubMed ID: 18680705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
    Beccastrini E; D'Elios MM; Emmi G; Silvestri E; Squatrito D; Prisco D; Emmi L
    Int J Immunopathol Pharmacol; 2013; 26(3):585-96. PubMed ID: 24067455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-FABP: A novel biomarker of kidney disease.
    Xu Y; Xie Y; Shao X; Ni Z; Mou S
    Clin Chim Acta; 2015 May; 445():85-90. PubMed ID: 25797895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glomerulonephritis, Th1 and Th2: what's new?
    Tipping PG; Kitching AR
    Clin Exp Immunol; 2005 Nov; 142(2):207-15. PubMed ID: 16232206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of innate immunity in septic acute kidney injuries.
    Gonçalves GM; Zamboni DS; Câmara NO
    Shock; 2010 Sep; 34 Suppl 1():22-6. PubMed ID: 20523275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding autoimmune disease: new targets for drug discovery.
    Balagué C; Kunkel SL; Godessart N
    Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Many cytokines are very useful therapeutic targets in disease.
    Feldmann M
    J Clin Invest; 2008 Nov; 118(11):3533-6. PubMed ID: 18982159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-cytokine fusion proteins.
    Kontermann RE
    Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
    Siebert S; Tsoukas A; Robertson J; McInnes I
    Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orchestrating innate immune responses in multiple sclerosis: molecular players.
    Fernández M; Montalban X; Comabella M
    J Neuroimmunol; 2010 Aug; 225(1-2):5-12. PubMed ID: 20537409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells and autoimmune heart failure.
    Marty RR; Eriksson U
    Int J Cardiol; 2006 Sep; 112(1):34-9. PubMed ID: 16891018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term Effects of Acute Kidney Injury.
    Singbartl K; Joannidis M
    Crit Care Clin; 2015 Oct; 31(4):751-62. PubMed ID: 26410142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury.
    Panizo N; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; Moreno JA
    Kidney Blood Press Res; 2015; 40(5):520-32. PubMed ID: 26512883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.